News

Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
Investing.com-- TD Cowen downgraded its rating on Sarepta Therapeutics Inc (NASDAQ: SRPT) and slashed its price target ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. UBS upgraded ...
The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
For the second time, a person with DMD has died of acute liver failure after being treated with the one-time gene therapy Elevidys.
Chinese artificial intelligence startup MiniMax is planning an initial public offering in Hong Kong that could happen as early as this year, according to a Bloomberg report on Wednesday.
Aldeyra has resubmitted its new drug application for reproxalap, an investigational dry eye treatment, which contained new ...
The latest inflation data comes on the eve of a Bank of England decision on interest rates when they are expected to be left ...